Nephritic syndrome

Nephritic syndrome is a clinical syndrome of glomerular inflammation rather than a single disease. In the evidence concerning hepatitis C virus infection, it denotes a potentially severe renal presentation in which hematuria and declining filtration may accompany proteinuria, with acute renal failure in the most aggressive cases. Its significance lies in linking a systemic viral and immune process to kidney injury: hepatitis C virus can produce mixed cryoglobulinemia, cryoglobulinemic vasculitis, and cryoglobulinemic membranoproliferative glomerulonephritis, while similar findings in people with HIV/HCV coinfection or kidney transplants require careful pathological discrimination.

Clinical Definition and Presentation

Nephritic syndrome appears in the evidence as one end of a spectrum of renal involvement. In patients with mixed cryoglobulinemia, kidney disease may instead present with non-nephrotic or nephrotic proteinuria, hematuria, and variable reduction in estimated glomerular filtration rate. Acute nephritic syndrome occurs in about 25% of these patients, whereas nephrotic syndrome occurs in about 20%, showing that the same systemic disorder can produce markedly different clinical patterns.

In HIV/HCV coinfection, the range extends from persistent non-nephrotic proteinuria and microscopic hematuria with preserved renal function to nephrotic syndrome and macroscopic hematuria accompanied by acute renal failure. The syndrome therefore cannot be identified by one laboratory abnormality alone. Its interpretation depends on the combination of urinary findings, renal function, systemic manifestations, serologic evidence, and, when appropriate, renal biopsy.

Hepatitis C and Cryoglobulinemic Disease

Hepatitis C virus infection is described as the major cause of mixed cryoglobulinemia, a systemic vasculitis that may include arthralgias, arthritis, Raynaud phenomena, purpura, peripheral neuropathy, hypocomplementemia, and kidney disease. Cryoglobulins are essential to the diagnosis, and hepatitis C virus RNA is usually detectable in serum; positive rheumatoid factor and low complement may provide additional support. Purpura, joint symptoms, or neuropathy can precede renal disease by several years, so the nephritic presentation may be a late expression of a broader systemic process rather than its first sign.

The renal lesion most frequently associated with this setting is type I membranoproliferative glomerulonephritis, also called cryoglobulinemic glomerulonephritis. In an active chronic hepatitis C virus infection, defined by both anti-hepatitis C virus antibodies and detectable hepatitis C virus RNA for more than six months, evaluation must address both hepatic and extrahepatic effects, including cryoglobulinemia-associated vasculitis. Confirmation of active infection depends on RNA detection, not antibody positivity alone, because antibodies may persist after resolved infection.

Pathology and Severity

The pathological pattern helps explain why nephritic syndrome may be mild and slowly progressive in one patient but rapidly destructive in another. Massive intraluminal thrombi, vasculitis, or both are more common in patients with acute nephritic syndrome and rapid progression toward kidney failure. Exudative or lobular membranoproliferative glomerulonephritis is associated with nephritic and/or nephrotic presentations, while mesangioproliferative glomerulonephritis more often produces proteinuria and microscopic hematuria with normal renal function.

In HCV-associated disease, renal biopsy may show mesangial proliferation, double contours of glomerular capillaries, immunoglobulin G, immunoglobulin M, and complement component 3 deposits, subendothelial electron-dense deposits, and cryoglobulin thrombi occluding capillary lumens. In some cases, vasculitis also affects extraglomerular vessels. These findings place nephritic syndrome within an immune-complex and cryoglobulin-mediated process rather than treating it as an isolated urinary abnormality.

The outcome is variable. Renal disease slowly progresses in most patients and does not necessarily lead to kidney failure despite persistent proteinuria and impaired renal function; even some cases with massive thrombi and vasculitis can reverse spontaneously. Older age, recurrent purpura, elevated cryocrit, hypocomplementemia, and high serum creatinine at diagnosis are identified as risk factors for progression to end-stage renal disease.

Diagnosis in Broader Clinical Contexts

Screening for hepatitis C virus infection relies on detecting anti-hepatitis C virus antibodies, commonly with third-generation enzyme-linked immunosorbent assays, followed by molecular testing for hepatitis C virus RNA. In kidney transplant candidates, the distinction between exposure and active infection is particularly consequential: in low-prevalence regions, enzyme immunoassay can be used initially and positive results confirmed with nucleic acid testing, whereas nucleic acid testing should be the first-line test in high-prevalence settings because a negative antibody assay cannot reliably exclude infection.

Active chronic infection also requires assessment of liver injury and fibrosis, using liver biopsy or noninvasive methods such as FibroScan and biochemical fibrosis scores. This matters because nephritic syndrome may coexist with clinically silent but advanced liver disease, and because treatment decisions must account for both renal and hepatic consequences. Hepatitis C virus is presented as a systemic disease capable of producing autoimmune, dermatological, and renal disease, not merely as a disorder of the liver.

Nephritic Syndrome After Kidney Transplantation

After kidney transplantation, HCV-infected allograft recipients remain vulnerable to immune-complex-mediated glomerulonephritis. De novo membranoproliferative glomerulonephritis was reported in HCV-infected renal allograft recipients, and subsequent observations identified type II mixed cryoglobulinemia with an IgM-kappa monoclonal component in patients who developed post-transplant glomerulonephritis. Cryocrit levels are usually very low, often below 5%, which can make cryoglobulins difficult to detect and characterize; hepatitis C virus RNA may nevertheless be much more concentrated in the cryocrit than in serum, supporting a pathogenic role for the virus.

Clinical manifestations in the allograft include hypertension, microscopic hematuria, proteinuria, renal dysfunction, and occasional nephrotic syndrome. Biopsy may show chronic injury in several compartments, mesangial proliferation, double contours, and parietal immunoglobulin M and complement component 3 deposits. Electron microscopy can be necessary to distinguish membranoproliferative glomerulonephritis, with subendothelial electron-dense deposits, from transplant glomerulopathy, in which radiolucent areas appear in the glomerular basement membrane. The two lesions can coexist, reflecting the combined harmful effects of humoral immunity and hepatitis C virus-associated autoimmunity.

The transplant setting also sharpens the need for differential diagnosis. HIV-infected patients, whether or not they are coinfected with hepatitis C virus, may develop several forms of immune-complex glomerulonephritis with varied morphology and clinical expression. Accordingly, nephritic syndrome in an HCV/HIV-coinfected patient should prompt suspicion of HCV-induced cryoglobulinemic membranoproliferative glomerulonephritis, but renal biopsy remains important when not contraindicated. Associations between hepatitis C virus and other lesions, including membranous glomerulonephritis, are described as weak or uncertain when cryoglobulins, immune complexes, and complement activation are absent.